A Focus on the Inflation Reduction Act

Curious how the healthcare provisions in the Inflation Reduction Act will impact your business? Start with this booklet by key experts from PRECISIONvalue where 5 experts weigh in on how the Inflation Reduction Act will affect payers in addition to 2023 trends, events, and developments in the payer world. Download the booklet.

LEARN MORE

A Focus on the Inflation Reduction Act2023-05-08T11:33:05-04:00

Opportunities and challenges surrounding financial models for high-investment medications: A survey of access decision-makers and employers

As an increasing number of cell and gene therapies are US Food and Drug Administration approved, health care stakeholders are attempting to strike a balance between patient access to innovative treatments and overall affordability. Read about the survey by Precision's Erin Lopata, Christopher Terrone and Ami Gopalan to understand how access decision-makers and employers are using innovative financial models to support coverage of high-investment medications.

LEARN MORE

Opportunities and challenges surrounding financial models for high-investment medications: A survey of access decision-makers and employers2023-07-12T12:47:15-04:00

Price Controls and Competition

The Inflation Reduction Act will shift formulary development and contracting dynamics. Time for manufacturers to have a clear, persuasive value story. Learn more from PRECISIONvalue expert Erin Lopata.

LEARN MORE

Price Controls and Competition2023-07-12T12:07:31-04:00